BCMO
GSK icon

Buckingham Capital Management (Ohio)’s GSK GSK Stock Holding History

Buckingham Capital Management (Ohio)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-15,851
Closed -$835K – 142
2017
Q1 		$835K Buy
15,851
+789
+5% +$40K 0.2% 110
2016
Q4 		$725K Buy
15,062
+744
+5% +$36.8K 0.18% 113
2016
Q3 		$773K Buy
14,318
+1,678
+13% +$92K 0.2% 110
2016
Q2 		$685K Buy
12,640
+1,208
+11% +$63.6K 0.18% 119
2016
Q1 		$579K Buy
11,432
+190
+2% +$9.46K 0.16% 122
2015
Q4 		$567K Sell
11,242
-564
-5% -$28.7K 0.16% 126
2015
Q3 		$567K Buy
11,806
+1,133
+11% +$59K 0.17% 129
2015
Q2 		$564K Buy
10,673
+1,219
+13% +$68.6K 0.16% 130
2015
Q1 		$545K Buy
9,454
+105
+1% +$6.02K 0.16% 132
2014
Q4 		$499K Buy
9,349
+219
+2% +$12.3K 0.15% 128
2014
Q3 		$525K Sell
9,130
-212
-2% -$13K 0.16% 125
2014
Q2 		$624K Buy
9,342
+1,257
+16% +$85.1K 0.2% 123
2014
Q1 		$540K Buy
8,085
+515
+7% +$34.8K 0.18% 129
2013
Q4 		$505K Sell
7,570
-40
-0.5% -$2.59K 0.18% 127
2013
Q3 		$480K Buy
7,610
+460
+6% +$29.6K 0.2% 126
2013
Q2 		$447K Buy
+7,150
New +$454K 0.18% 128

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Buckingham Capital Management (Ohio)'s GSK Position: Q2 2017 in Review

Buckingham Capital Management (Ohio) sold out of GSK (GSK) in Q2 2017, closing a stake of 15,851 shares — an estimated $835K sold.

Buckingham Capital Management (Ohio) first reported a position in GSK in Q2 2013 and held it in 16 quarters. The position peaked at $835K in Q1 2017. 779 funds tracked by Wall St. Rank hold GSK as of Q2 2017.

  • Buckingham Capital Management (Ohio) reported no remaining GSK position as of Q2 2017 after selling out during the quarter.
  • Buckingham Capital Management (Ohio) sold 15,851 GSK shares in Q2 2017, an estimated $835K.
  • Buckingham Capital Management (Ohio) first reported a position in GSK in Q2 2013 and held it in 16 quarters.
  • Buckingham Capital Management (Ohio)'s GSK position peaked at $835K in Q1 2017.
  • 779 funds tracked by Wall St. Rank held GSK as of Q2 2017.

Based on Buckingham Capital Management (Ohio)'s 13F filing for Q2 2017, filed 10 Aug 2017.